# M4E(R2):  The CTD – Efficacy - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/m4er2-the-ctd-efficacy/460793c4-42d9-4f9f-83c0-9ec5b1d6151d

> FDA guidance document: M4E(R2):  The CTD – Efficacy. Issue date: July 24, 2017. Get complete insights and analysis.

---

## Details

- Title: M4E(R2):  The CTD – Efficacy
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-07-24
- Last Changed: 2025-02-03
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2015-D-3235">FDA-2015-D-3235</a>

## Related Documents

- [Q3C Tables and List Rev 4](https://www.globalkeysolutions.net/guidances/guidance-document/q3c-tables-and-list-rev-4/603912c9-dba1-4b46-ba60-7454fec624a0)
- [E8(R1) General Considerations for Clinical Studies](https://www.globalkeysolutions.net/guidances/guidance-document/e8r1-general-considerations-for-clinical-studies/c5e52286-b058-4b0f-b1f2-e589be1aaf84)
- [Labeling for Biosimilar Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/labeling-for-biosimilar-products-guidance-for-industry/e13343b3-e9e8-436e-9bcc-ec73cae4d41c)